• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Duration of paroxysmal atrial fibrillation in cryptogenic stroke is not associated with stroke severity and early outcomes
The current definition of paroxysmal atrial fibrillation (PAF) requires an arbitrary cut-off of>30s, but in clinical practice cryptogenic stroke (CS) patients with PAF duration of ≤30s are not usually excluded from anticoagulation therapy. We sought to evaluate the clinical relevance of short-duration (≤30s) PAF in CS. Consecutive CS patients with no prior AF history and sinus-rhythm on baseline electrocardiography (ECG) were prospectively evaluated over a three-year peri od. Baseline stroke severity was assessed by NIHSS-scores.
Source: Journal of the Neurological Sciences - March 23, 2017 Category: Neurology Authors: Chrissoula Liantinioti, Konstantinos Tympas, Aristeidis H. Katsanos, John Parissis, Maria Chondrogianni, Christina Zompola, Georgios Papadimitropoulos, Michael Ioakeimidis, Sokratis Triantafyllou, Andromaxi Roussopoulou, Konstantinos Voumvourakis, John Le Source Type: research

Diagnostic value of N-terminal pro B-type natriuretic peptide for nonvalvular atrial fibrillation in acute ischemic stroke patients: A retrospective multicenter case-control study
The objective of this study is to evaluate the N-terminal pro B-type natriuretic peptide (NT-proBNP) diagnostic value for NVAF and the clinical outcome of AIS patients.
Source: Journal of the Neurological Sciences - April 5, 2020 Category: Neurology Authors: Jingjing Zhao, Yi Zhang, Fang Yuan, Changgeng Song, Yongli Jiang, Qiong Gao, Xiuxiu Leng, Wen Jiang Source Type: research